the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Reactivate talent development programme in welfare institutions – Nancy

KUCHING: Talent Development Programme, especially that involving children in Social Welfare Department institutions, needs to be reactivated, said Minister of Women, Family and Community Development (KPWKM) Datuk Seri Nancy Shukri.

She said that through such a programme, welfare institutions can identify the ability and hidden talent of children, in addition to helping them build their self-confidence.

“We need to explore their talents, if they have a talent and expertise, Insha-Allah they can be independent and have a career based on their interest,” she told reporters after attending the ‘Tautan Kasih Ramadan’ event at Rumah Kanak-Kanak Toh Puan Hajah Norkiah here today.

Speaking at the function, Nancy said her ministry is very concerned with the needs of targeted groups, particularly those involving children and senior citizens.

“Various programmes need to be held and activated to enable them to interact and enjoy the protection and care that they deserve in line with the National Policy on Children, Child Act 2001 and National Policy on Older Persons.

“The cooperation of various parties, be it individuals, private sector, non-governmental organisations, (or) corporate sector is very crucial in us achieving the country’s aspirations, especially in terms of social and welfare,” she said.

She added that by dedicating a little time and energy and providing mental as well as spiritual support, one can bring happiness to the children and residents in both of these institutions.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings